semaglutide treatment milwaukee Why some are calling a new weight loss drug a game-changer Sustainable weight loss isn't about

FDA: unapproved GLP-1 drug safety concerns Regulator Used for safety language around compounded, counterfeit, and unapproved GLP-1 products

Researchers found that 86.4% of adults who took semaglutide were able to lose at least 5% of their baseline body weight during the trial, compared with only 31.5% who only followed lifestyle interventions

consultation with a qualified physician remains important for making the optimal choice

Slows gastric emptying, helping you feel full longer after meals

The outreach effort was limited by clinician time constraints as there were no dedicated personnel for this real world intervention

So if you are staring at a pink vial right now, take a breath